The new epidemiology: Putting the pieces together in complex disease aetiology

International Journal of Epidemiology

Volumn 33, Issue 5, 2004, Pages 925-928

  Palmer, Lyle J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; GENETICS;

ALLELE; EDITORIAL; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE MAPPING; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; MEDICAL GENETICS; MEDICAL LITERATURE; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EPIDEMIOLOGIC METHODS; EPIDEMIOLOGY, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 7244229696     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh326     Document Type: Editorial

References (49)

1. Khoury MJ. Genetic epidemiology and the future of disease prevention and public health. Epidemiol Rev 1997;19:175-80.
2. Nagy A, Perrimon N, Sandmeyer S, Plasterk R. Tailoring the genome: the power of genetic approaches. Nat Genet 2003;33 Suppl.): 276-84.
3. Zerhouni E. Medicine. The NIH Roadmap. Science 2003; 302:63-72.
4. Goldstein DB, Tate SK, Sisodiya SM. Pharmacogenetics goes genomic. Nat Rev Genet 2003;4:937-47.
5. Merikangas KR, Risch N. Genomic priorities and public health. Science 2003;302:599-601.
6. Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ. The role of genetic polymorphisms in environmental health. Environ Health Perspect 2003;111:1055-64.
7. Shostak S. Locating gene-environment interaction: at the intersections of genetics and public health. Soc Sci Med 2003; 56 2327-42.
8. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-99.
9. Burke W. Genomics as a probe for disease biology. N Engl J Med 2003;349:969-74.
10. Johnson JA. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet 2003;19:660-66.
11. Khoury MJ, Millikan R, Little J, Gwinn M. The emergence of epidemiology in the genomics age. Int J Epidemiol 2004;33 936-44.
12. Jablonka E. Epigenetic epidemiology. Int J Epidemiol 2004;33:929-35.
13. Iliadou A, Cnattingius S, Lichtenstein P. Low birthweight and type 2 diabetes: a study on 11 162 Swedish twins. Int J Epidemiol 2004;33:948-53.
14. Sparks R, Bigler J, Sibert JG, Potter JD, Yasui Y, Ulrich CM. TGβ1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps. Int J Epidemiol 2004;33:955-61.
15. Lewis SJ, Brunner EJ. Methodological problems in genetic association studies of longevity: the apolipoprotein E gene as an example. Int J Epidemiol 2004;33:962-70.
16. McKeown-Eyssen G, Baines C, Cole DEC et al. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2, and MTHFR. Int J Epidemiol 2004;33 971-78.
17. Morita A, Iki M, Dohi M et al. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of the Japanese Women-Japanese population-based Osteoporosis (JPOS) Study. Int J Epidemiol 2004;33:979-88.
18. Keavney B, Palmer A, Parish S et al. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations and coronary disease risk. Int J Epidemiol 2004;33:1002-13.
19. Gatto NM, Campbell UB, Rundle AG, Ahsan H. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. Int J Epidemiol 2004;33:1014-24.
20. McNeill G, Tuya C, Smith WCS. The role of genetic and environmental factors in the association between birthweight and blood pressure: evidence from meta-analysis of twin studies. Int J Epidemiol 2004;33:995-1001.
21. Venter JC, Levy S, Stockwell T, Remington K, Halpern A. Massive parallelism, randomness and genomic advances. Nat Genet 2003;33(Suppl.):219-27.
22. Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 1992;3:783-91.
23. Palmer LJ, Knuiman MW, Divitini ML et al. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur Respir J 2001;17:696-702.
24. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33(Suppl.):228-37.
25. Cardon LR, Watkins H. Waiting for the working draft from the human genome project: a huge achievement, but not of immediate medical use. Br Med J 2000;320:1221-22.
26. Sachidanandam R, Weissman D, Schmidt SC et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-33.
27. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
28. Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000;58: 250-64.
29. Gray IC, Campbell DA, Spurr NK. Single nucleotide polymorphisms as tools in human genetics. Hum Mol Genet 2000; 9 2403-8.
30. Keavney B. Genetic association studies in complex diseases. J Hum Hypertens 2000;14:361-67.
31. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 2001;69:936-50.
32. The International HapMap Project. The International HapMap Project. Nature 2003;426:789-96.
33. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004;5 89-100.
34. Ohlstein EH, Ruffolo RR, Jr, Elliott JD. Drug discovery in the next millennium. Annu Rev Pharmacol Toxicol 2000;40 177-91.
35. Chanda SK, Caldwell JS. Fulfilling the promise: drug discovery in the post-genomic era. Drug Discov Today 2003;8 168-74.
36. Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med 2003;348:50-58.
37. Goldstein DB, Ahmadi KR, Weale ME, Wood NW. Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 2003;19:615-22.
38. Silverman EK, Palmer LJ. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 2000;22:645-48.
39. Dahlman I, Eaves IA, Kosoy R et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-50.
40. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
41. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
42. Tabor HK, Risch NJ, Myers RM. Opinion. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391-97.
43. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet 2000;26:151-57.
44. Terwilliger JD, Goring HH. Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design. Hum Biol 2000;72:63-132.
45. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-09.
46. Goring HH, Terwilliger JD, Blangero J. Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 2001;69:1357-69.
47. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-17.
48. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
49. Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359 727-32.